zidovudine has been researched along with sc 52151 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, M; Clare, M; DeCrescenzo, G; Dillard, R; Getman, D; Heintz, R; Houseman, K; Lansky, D; Marr, J; Smidt, M | 1 |
| Corbeil, J; Moutouh, L; Richman, DD | 1 |
| Gold, D; Loftus, R | 1 |
3 other study(ies) available for zidovudine and sc 52151
| Article | Year |
|---|---|
SC-52151, a novel inhibitor of the human immunodeficiency virus protease.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; Dogs; Drug Synergism; HIV; HIV Protease Inhibitors; Humans; Macaca mulatta; Molecular Sequence Data; Protein Binding; Rats; Rats, Sprague-Dawley; Urea; Zidovudine | 1995 |
Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure.
Topics: Amino Acid Sequence; Base Sequence; Cell Line; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Recombination, Genetic; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Serial Passage; Urea; Zidovudine | 1996 |
Protease inhibitors: where are they now?
Topics: Animals; Blood Proteins; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Industry; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Oligopeptides; Protein Binding; Pyrones; Quinolines; Rats; Saquinavir; Technology, Pharmaceutical; Urea; Warfarin; Zidovudine | 1995 |